Patent · US Expired

Method for reducing the risk of developing diabetes

US5725860A · kind A · utility

1Cited by
0References
7Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 7, 1996
Grant dateMar 10, 1998
Priority date
Expiry dateAug 7, 2016

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55594
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The incidence of the autoimmune disease, diabetes mellitus, is well controlled in the nude-obese-diabetic (NOD) mouse model using injections of the A chain fragment (or parts thereof) of the insulin molecule as an antigen in combination with killed cells (or parts thereof) of Haemophilus pertussis, acting as an adjuvant. This leads to the convenient prevention of diabetes in humans using the common "Triple vaccine" (DPT) diphtheria/whooping cough/tetanus vaccine (or versions thereof) in combination with A chain fragment of insulin. This mixture can be given to an at-risk population in which diabetes is expected to occur at an abnormally high rate, or it can be given to the entire population.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.